A recorded conversation led by Robert Whitfield MD about explant (breast implant removal) surgery focused on safety considerations: how pre-operative toxin/inflammation testing (mold, heavy metals, urine inflammation markers) can influence surgical planning and limits on procedures (e.g., avoiding or limiting fat transfers) when a patient has a poor toxicology profile. The clip also includes patient preferences about lift outcomes.
Also, you're able to compare it to when you get the explant out, which I think is like, knowledge is power, right?
And you want to supplement those, too. As time.
Goes by, are there things you'll see when someone comes to you in their test? You're like, I can't operate on you until you do these certain things or just certain things they may have that prohibits them from having an explant. So from an.
Explant alone perspective, typically not. But if someone's got a very, very poor tox profile with mold and heavy metals, lots of environmental exposures, and we do an associated urine test for just inflammation, if that's all really super high, then we try to be careful with how much surgery we were doing. So we will limit things like fat transfers because we don't want to reduce the healing ability of that fat transfer.
And you did not want to do. Just so I can tell everyone what I did, I got them out the M block, right. And I wanted to do a lift. The best lift that you could possibly do. I wanted the highest nipples.
